Program
of the International Conference
“Fifth Kazakhstan Venous Forum”
June 4–5, 2026, Astana, Kazakhstan
Please, download the Final Scientific Program of the Fifth Kazakhstan Venous Forum here
Day 1
June 4 ,2026, Thursday
Hotel Wyndham Garden Astana Hotel, “Altai” Hall, 1st Floor
|
7:00-8:00
|
Registration |
|
8:00-8:15 |
Opening Ceremony Welcome address: Ministry of Health of the Republic of Kazakhstan Prof. Shaidakov E.V. (Saint Petersburg, Russia), President of the Saint Petersburg Venous Forum, President of the Saint Petersburg Society of Phlebology Prof. Fokin A.A. (Chelyabinsk, Russia) President of the Euro-Asian Association of Angiologists and Vascular Surgeons Prof. Sunnatov R.D. (Tashkent, Uzbekistan), President of the Association of Phlebologists of Uzbekistan Prof. Gianesini Sergio (Ferrara, Italy), President of the World Union of International Phlebo-lymphology (WUIP) online Prof. Lazarashvili Zaza (Tbilisi, Georgia) President-elect of the World Union of International Phlebo-lymphology (WUIP) Prof. Sultanaliyev T.A. (Astana, Kazakhstan), President of the 5th Kazakhstan Venous Forum, President of the Kazakhstan Society of Vascular Surgeons (KSVS), President of the Kazakh Society of Phlebology (KSP) |
|
8:15-09:33 |
Session 1: Deep Veins (Presentation – 7 min, Questions – 2 min) Moderators: Smailov A.S. (Kazakhstan), Fokin A.A. (Russia), Tursunov B.Z. (Uzbekistan), Tursynbayev S.E. (Kazakhstan) |
|
8:15-8:24 |
Fokin A.A. (Russia) VTE prevention in the early period of intracranial hemorrhage episodes: “grey zone” of current clinical guidelines. |
|
8:24-8:33 |
Sunnatov R.D. (Uzbekistan) Optimization of conservative treatment of acute deep vein thrombosis of the lower limbs |
|
8:33-8:42 |
Seredytsky A.V. (Russia) Use of endovascular technologies in the treatment of acute deep vein thrombosis of the lower limbs |
|
8:42-8:51 |
Mukhametova N.D. (Kazakhstan, Almaty) Duplex angioscanning in diagnosis and prevention of VTE |
|
8:51-9:00 |
Azimbayev G.S. (Kazakhstan, Almaty) Total venous thrombosis: successful use of the EKOS system – clinical case review |
|
9:00-9:09 |
Mun E.V. (Kazakhstan, Astana) IVC filter removal: technical aspects and outcomes of own case series |
|
9:09-9:18 |
Aitbayev B.K. (Kazakhstan, Almaty) AI in reproduction of clinical cases of inferior vena cava injury |
|
9:18-9:27 |
Aslim Erdal (Turkey) Interventional management of deep vein thrombosis in pregnancy: safety, risks, and benefits |
|
9:27-9:33 |
Conclusions: Fokin A.A.
|
|
09:33-11:00 |
Session 2: Drug Therapy for Chronic Venous Disease Moderators: Shaidakov E.V. (Russia), Sunnatov R.D. (Uzbekistan), Kospanov N.A. (Kazakhstan), Sagandykov I.N. (Kazakhstan) |
|
09:34-9:49 |
Fokin A.A. (Russia) Treatment of vein-specific symptoms in post-thrombotic syndrome of the lower limbs (Innotech) |
|
9:50-10:05 |
Lobastov K.V. (Russia) Optimal anticoagulation therapy in patients with cancer-associated thrombosis (online/ Bayer) |
|
10:06-10:14 |
Sagandykov I.N. (Kazakhstan, Astana) Prevention and treatment of thrombotic complications in cancer patients: focus on DOACs (Egis) |
|
10:15-10:30 |
Lobastov K.V. (Russia) How to prevent recurrence of varicose disease after surgical treatment (online/Servier) |
|
10:31-10:39 |
Ryzhkov A.G. (Kazakhstan, Shymkent) Evaluation of the efficacy of triple venoactive therapy in patients with CVD C2: real-world evidence |
|
10:41-10:51 |
Shaidakov E.V. (Russia) Biological activity of venoactive drugs. A new step in the development of clinical phlebology |
|
10:51-11:00 |
Discussion
|
|
11:00-11:20
|
Coffee-break, exhibition visit |
|
11:20-12:45 |
Session 3: Pelvic Veins (Presentation – 6 min, Questions – 2 min) Moderators: Lazarashvili Z. (Georgia), Zemlyansky V.V. (Kazakhstan), Aidashova B.B. (Kazakhstan), Temirov S.N. (Uzbekistan) |
|
11:20 -11:28 |
Aidashova B.B. (Kazakhstan, Almaty) Ultrasound diagnosis of pelvic vein diseases |
|
11:28-11:36 |
Temirov S.N. (Uzbekistan) Role of MR-phlebography in selecting treatment strategy for pelvic venous congestion |
|
11:36-11:44 |
Mun E.V. (Kazakhstan, Astana) Endovascular treatment of pelvic varicose veins |
|
11:44-11:52 |
Bildebekov E.A. (Kazakhstan, Almaty) Pelvic vein embolization: single-center experience |
|
11:52-12:00 |
Tulemisov A.K. (Kazakhstan, Astana) Efficacy of liquid embolization of pelvic varicose veins in pelvic PCS compared with coil embolization |
|
12:00-12:08 |
Iliyev S.A. (Kazakhstan, Almaty) Pathogenetically justified surgical approaches to treatment of PCS |
|
12:08-12:16 |
Suynbekova A.S. (Kazakhstan, Astana) Results of gonadal vein embolization for pelvic varicose veins |
|
12:16-12:24 |
Aidashova B.B. (Kazakhstan, Almaty) Pelvic perforators as a cause of recurrent lower limb varicose veins |
|
12:24-12:32 |
Kozhamkul A. Zh. (Kazakhstan, Almaty) Ovarian vein embolization in pelvic venous congestion syndrome |
|
12:32-12:40 |
Bildebekov E.A. (Kazakhstan, Almaty) Possible complications of pelvic vein embolization |
|
12:40-12:45 |
Conclusions: Lazarashvili Z.
|
|
12:45-13:45
|
Lunch break. Exhibition visit
|
|
12:50-13:10
|
Lunch Symposium: Abdi Ibrahim Moderator: TBD Kelimbetov R.M. (Kazakhstan, Shymkent) Anticoagulant therapy for VTE: current dosage regimens |
|
13:45-14:55 |
Session 4: Treatment of Chronic Venous Disease (Presentation – 6 min, Questions – 2 min) Moderators: Bespayev A.T. (Kazakhstan), Bogachev V.Yu. (Russia), Fattah-Pur V. (Azerbaijan) |
|
13:45-13:53 |
Sunnatov R.D. (Uzbekistan) New perspectives on management of patients with trophic ulcers due to chronic venous insufficiency |
|
13:53-14:01 |
Shaidakov E.V. (Russia) Regarding the management of trophic ulcers |
|
14:01-14:09 |
Fattah-Pur Vugar (Azerbaijan) Optimal diagnostic and treatment strategy for mixed arteriovenous ulcers of the lower limbs |
|
14:09-14-17 |
Jindal Ravul (India) Management of arteriovenous malformations |
|
14:17-14:25 |
Jindal Ravul (India) How to improve the results in foam sclerotherapy |
|
14:25-14:33 |
Arias Luis (Bolivia) Management of varicose ulcers |
|
14:33-14:41 |
Imai Takahiro (Japan) Non-thermal ablation for lower extremity varicose veins |
|
14:41-14:49 |
Iliyev S.A. (Kazakhstan, Almaty) Endovascular revascularization of central veins: current possibilities and outcomes |
|
14:49-14:55 |
Discussion
|
|
14:55-15:34 |
Session 5: vWIN foundation “Road to Kenya Le.G.athering World Congress” (Presentation – 6 min, Comment – 2 min) Moderators: Arias Luis (Bolivia), Lazarashvili Z. (Georgia), TBD |
|
14:55-14:57 |
Opening remarks by moderators |
|
14:58-15:04 |
Gianesini Sergio (Italy) Le.G.athering” project: a multi-specialty call to appropriate vein-lymphatic care |
|
15:04-15:06 |
Comment: Sharipov A.S. (Kazakhstan) |
|
15:07-15:13 |
Jindal Ravul (India) Diabetic foot notions all vein experts should know. |
|
15:13-15:15 |
Comment: Temirov S.N. (Uzbekistan) |
|
15:16-15:22 |
Lazarashvili Zaza (Georgia) Modern management of PeVD: example of multi-speciality collaboration |
|
15:22-15:24 |
Comment: Zemlyansky V.V. (Kazakhstan) |
|
15:24-15:34 |
Discussion
|
|
15:35-16:06 |
Session 6: World International Union of Phlebo-lymphology (WUIP) “Similarities and Discrepancies in Global Phlebolymphology” (Presentation – 5 min, Comment – 2 min) Moderators: Gianesini S. (Italy), Shaidakov E.V. (Russia), Jindal R. (India) |
|
15:35-15:37 |
Opening remarks by moderators |
|
15:38-15:43 |
Shaidakov E.V. (Russia) Glue vs laser: where do we stay |
|
15:43-15:45 |
Comment: Arias Luis (Bolivia) |
|
15:46-15:51 |
Udris Ints (Latvia) Laser vs glue: where do we stay |
|
15:51:15:53 |
Comment: Suleymenov E.T. (Kazakhstan) |
|
15:54-15:59 |
Imai Takahiro (Japan) Compression unmet needs in vein care |
|
15:59-16:01 |
Comment: Chinaliyev A.M. (Kazakhstan) |
|
16:01-16:06 |
Conclusions: Jindal Ravul (India)
|
|
16:06-16:30
|
Coffee break, exhibition visit |
|
16:30-18:00 |
Session 7: Symposium «Global Vein & Lymphatic University at the Kazakhstan Venous Forum” (Hybrid format) (Presentation – 5 min, Comment – 2 min) Chairs: Lowell Kabnick (USA), Victor Kanata (Paraguay) Moderators: Shaidakov E.V. (Russia), Jindal Ravul (India), Sharipov A.S. (Kazakhstan) |
|
16:30-16:32 |
Lowell Kabnick (USA) Introduction |
|
16:33-16:40 |
Imre Bihari (Hungary) Why Perform Laser Crossectomy: What is the Evidence? |
|
|
Comment: Guttenberg Gurgel (Brazil) |
|
16:41-16:48 |
Guttenberg Gurgel (Brazil) Artificial Intelligence: the Most Important Venous Practice Changes |
|
|
Comment: Imre Bihari (Hungary) |
|
16:49-16:56 |
Alejandro Gonzalez (Mexico) Venoactive Drugs Post Venous Intervention and in C6 Patients |
|
|
Comment: Askhat Sharipov (Kazakhstan) |
|
16:57-17:04 |
Kurshat Bozkurt (Turkey) How Do I Treat a Failed Cyanoacrylate Closure |
|
|
Comment: Evgeniy Shaidakov (Russia) |
|
17:05-17:12 |
Dimitris Kontothanasis (Italy) When Do I Chose Phlebectomy or Sclerotherapy for Varicose Veins |
|
|
Comment: Jorge Ulloa (Colombia) |
|
17:13-17:20 |
Jorge Ulloa (Colombia) How Do I Treat Telangiectasias, Reticular Veins, Venulectasia: Liquid Vs Foam, Dry Foam Vs Wet Foam and or Laser |
|
|
Comment: Dimitris Kontothanasis (Italy) |
|
17:21-17:28 |
Alexandra Jaworucka-Kaczorowska (Poland) When and How to Treat Pelvic Venous Escape Points and Their Varicose Veins |
|
|
Comment: Ravul Jindal (India) |
|
17:29-17:36 |
Patrick Muck (USA) Percutaneous Management of Pulmonary Embolism: When and How |
|
|
Comment: Houman Jalaie (Germany) |
|
17:37-17:44 |
Houman Jalaie (Germany) How to Optimize Therapy for Chronic Venous Obstruction |
|
|
Comment: Patrick Muck (USA) |
|
17:45-17:52 |
Jinsong Wang (China) What Are the New Venous Ablative Devices in China |
|
|
Comment: Takahiro Imai (Japan) |
|
17:53-17:58 |
Audience General Questions |
|
17:59-18:00 |
Closing: Victor Kanata (Paraguay)
|
|
18:05-18:12 |
Presentation of the WUIP World Congress of Phlebology WUIP 2027, Tbilisi Zaza Lazarashvili (Georgia) |
|
18:13-18:20 |
Presentation of the WUIP World Congress of Phlebology WUIP 2029, Hong Kong Yung Wei Chi (USA), Jinsong Wang (China) (online) |
|
19:45
|
Gala Dinner: Wyndham Garden Astana Hotel. “Altai” Banquet Hall By invitation and ticket only
|
Day 2
June 5, 2026, Friday
Hotel Wyndham Garden Astana Hotel, “Altai” Hall, 1st Floor
|
09:00-10:10 |
Session 8: Thromboses, Endovascular Surgery, Open Surgery, Thermal Ablation (Presentation – 6 min, Questions – 2 min) Moderators: TBD |
|
9:00-9:08 |
Borkova S.A. (Kazakhstan, Astana) Concomitant thrombosis in the setting of diffuse peritonitis |
|
9:08-9:16 |
Bekbosynov A.Zh. (Kazakhstan, Astana) Post-injection complications of peripheral venous catheterization in modern clinical practice |
|
9:16-9:24 |
Yevseeva V.V. (Russia) Histological examination of thrombotic masses to determine the time of deep vein thrombosis development |
|
9:24-9:32 |
Baubekov A.A. (Kazakhstan, Almaty) Our experience in recanalization of vascular access complications in dialysis patients |
|
9:32-9:40 |
Soliev O.F. (Tajikistan) Endovenous thermal obliteration: comparative evaluation of radiofrequency and laser technologies for varicose vein treatment |
|
9:40-9:48 |
Abdimitalip uulu K. (Kyrgyzstan) EVLA in acute thrombophlebitis of the lower limbs in patients with varicose veins |
|
9:48-9:56 |
Jurakulov Sh.R. (Russia) Endovascular treatment of patients with liver cirrhosis complicated by portal hypertension in a flagship center |
|
9:56-10:04 |
Pernebayev B.S. (Kazakhstan, Astana) NCS: possibilities of open surgery. |
|
10:04-10:10 |
Discussion
|
|
10:11-11:30 |
Session 9: Superficial Veins, Thermal Ablation, Sclerotherapy, Aesthetic Phlebology (Presentation – 7 min, Questions – 2 min) Moderators: Kirgizbayev S.Zh., Kaztuganov Zh.K., Akanov E.K., Azimbayev G.S. |
|
10:11-10:20 |
Ibrayev M.K. (Kazakhstan, Astana) Comparative evaluation of complications of sclerotherapy and EVLA in varicose disease of the lower limbs |
|
10:20-10:29 |
Dzhumatayeva A.B. (Kazakhstan, Almaty) CLaCS with microsecond laser |
|
10:29-10:38 |
Kaztuganov Zh.K. (Kazakhstan, Uralsk) CLaCS: my choice – long-pulse or short-pulse laser? |
|
10:38-10:47 |
Azimbayev G.S. (Kazakhstan, Almaty) Recurrence of varicose veins of the lower limbs after open surgery |
|
10:47-10:56 |
Tadzhibayev T.K. (Kazakhstan, Almaty) Preservation of saphenous vein trunks in varicose disease for future arterial revascularization |
|
10:56-11:05 |
Onlasynov A.K. (Kazakhstan, Almaty) Modern methods of treatment of vascular anomalies |
|
11:05-11:14 |
Kaztuganov Zh.K. (Kazakhstan, Uralsk) ASVAL – a saphenous vein-preserving alternative in varicose disease treatment |
|
11:14-11:23 |
Kaztuganov Zh.K. (Kazakhstan, Uralsk) ASVAL – how I do it (video demonstration) |
|
11:23-11:30 |
Discussion
|
|
11:30-13:00 |
Session 10: Association of Phlebologists of Uzbekistan (Presentation – 7 min, Questions – 2 min) Moderators: Asamov R.E., Konysov M.N., Temirov S.N. |
|
11:30-11:39 |
Asamov R.E. (Uzbekistan) Experience with KemAngioprotez xenobioprothesis for vascular access formation for hemodialysis in patients with limited vascular resources |
|
11:39-11:48 |
Konysov M.N. (Kazakhstan, Atyrau) Mesenteric venous thrombosis: ESVS 2025 guidelines |
|
11:48-11:56 |
Zokirkhonov Sh.D. (Uzbekistan) CHIVA as an vein-preserving strategy: an evidence review |
|
11:56-12:05 |
Keldiyorov B.K. (Uzbekistan) Our experience in treating acute deep vein thrombosis of the lower limbs |
|
12:05-12:14 |
Khamdamov U.R. (Uzbekistan) Clinical efficacy of endovenous laser coagulation in varicose disease complicated by trophic disorders |
|
12:14-12:23 |
Adylkhanov F.T. (Kazakhstan, Astana) Recurrence of varicose veins after EVLA + miniphlebectomy: causes according to REVAS and the role of VEGF as a prognostic biomarker. |
|
12:23-12:32 |
Rakhmonov D.K. (Tajikistan) Iliofemoral segment stenting in post-thrombotic disease of the lower limbs |
|
12:32-12:41 |
Temirov S.N. (Uzbekistan) Features of iliac vein stenting |
|
12:41-12:50 |
Kim D.G. (Kazakhstan, Almaty) Endovascular treatment of pulmonary arteriovenous malformations: center experience |
|
12:50-13:00 |
Discussion
|
|
13:00-14:00
|
Lunch break. Exhibition visit |
|
14:00-15:40 |
Session 11: Lymphedema / Lipedema (Presentation – 8 min, Questions – 2 min) Moderators: Arias Luis (Bolivia), Kaplina M.Yu. (Russia), Dzhumatayeva A.B. (Kazakhstan) |
|
14:00-14:10 |
Kaplina M.Yu. (Russia) Physiological prerequisites for increased risk of lymphatic edema |
|
14:11-14:21 |
Saryyev N.N. (Kazakhstan, Astana) Comprehensive approach to lymphedema treatment |
|
14:22-14:32 |
Dzhumatayeva A.B. (Kazakhstan, Almaty) Compression bandaging in lymphedema: tips&tricks and common mistakes |
|
14:33-14:43 |
Arias Luis (Bolivia) Current Perspectives in Lymphedema Management |
|
14:44-14:54 |
Anapiya B.B. (Kazakhstan) Prospects for systematization and development of lymphedema treatment in Kazakhstan |
|
14:55-15:05 |
Ismailov A.A. (Uzbekistan) Surgical treatment of post-mastectomy lymphedema using lymphovenous anastomosis (LVA): our experience. |
|
15:06-15:16 |
Mendoza Erika (Germany) Lymphedema (online) |
|
15:17-15:27 |
Mendoza Erika (Germany) Lipedema (online) |
|
15:28-15:40 |
Discussion
|
|
15:40-16:10
|
Coffee break, exhibition visit |
|
16:10-18:10 |
Session 12: Superficial Veins, Thermal Ablation “20 Years of Endovenous Thermal Ablation in Kazakhstan” (Presentation – 8 min, Questions – 2 min) Moderators: Udris Ints (Latvia), Zokirkhonov Sh.D. (Uzbekistan), Alekseyev D.N. (Kyrgyzstan), Burumkulov E.R. (Kazakhstan) |
|
16:10-16:20 |
Bogachev V.Yu. (Russia) EVLA in varicose disease. Current trends. (IPG Photonics) |
|
16:21-16:31 |
Udris Ints (Latvia) 8 years together with TOTAL EVLA – where are we and where are we going? |
|
16:32-16:42 |
Umarov F.R. (Uzbekistan) Vacuum-assisted technology during EVLA of large-diameter saphenous veins for prevention of EHIT |
|
16:43-16:53 |
Alekseyev D.N. (Kyrgyzstan) Calculation of optimal LEED to prevent complications during EVLA |
|
16:54-17:04 |
Burumkulov E.R. (Kazakhstan, Almaty) EVLA: 20 years in Kazakhstan |
|
17:05-17:15 |
Aidashova B.B. (Kazakhstan, Almaty) Infinity (LGO): a new dimension in endovenous laser surgery (Zimar) |
|
17:16-17:26 |
Chinaliyev A.M. (Kazakhstan, Astana) Microwave ablation of GSV and SSV |
|
17:27-17:37 |
Burumkulov E.R. (Kazakhstan, Almaty) Total EVLA or navigational miniphlebectomy: what to choose for varicose tributaries? |
|
17:38-17:48 |
Borkova S.A. (Kazakhstan, Astana) Total EVLA: first results of method implementation |
|
17:49-17:59 |
Akilbekov G.N. (Kazakhstan, Astana) Rare complications of endovenous interventions |
|
18:00-18:10 |
Discussion
|
|
18:15 |
Certificate Award Ceremony Conference Closing
|